The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
By 2030, How Much Growth In Market Size Is Expected For The Arcalyst (rilonacept) Market?
The arcalyst (rilonacept) market has demonstrated robust growth in recent years. It is anticipated to expand from $0.24 million in 2025 to $0.26 million in 2026, at a compound annual growth rate (CAGR) of 7.3%. The market’s past growth can be attributed to factors such as the identification of IL-1 driven diseases, limited treatment alternatives for rare inflammatory conditions, strong clinical outcomes associated with rilonacept, regulatory approvals secured for orphan indications, and the increasing adoption of biologic therapies by specialists.
The Arcalyst (rilonacept) market is poised for substantial expansion in the upcoming years. It is forecasted to reach $0.33 million in 2030, demonstrating a compound annual growth rate (CAGR) of 6.5%. The projected increase during this period stems from factors such as an escalating diagnosis of autoinflammatory syndromes, its application in additional indications, advances in genetic screening, enhanced accessibility to biologic therapies, and a rise in investments targeting rare disease treatments. Noteworthy trends expected over the forecast period include a growing adoption of IL-1 blocking therapies, increased utilization in rare autoinflammatory disorders, the development of treatments for long-term inflammation management, a sharpened focus on targeted cytokine inhibition, and improved disease management for chronic inflammatory conditions.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19877&type=smp
Which Drivers Are Advancing The Arcalyst (rilonacept) Market Growth?
The increasing need for personalized medicines is projected to propel the expansion of the arcalyst (rilonacept) market moving forward. Personalized medicine defines a healthcare approach that customizes treatment plans and health decisions based on a patient’s unique attributes, such as their genetics, environment, and lifestyle. The impetus for personalized medicine is escalating due to its potential to enhance treatment efficacy, minimize adverse reactions, and address individual differences in disease progression and drug responsiveness. As personalized medicine gains wider adoption, there is enhanced awareness and improved diagnostic instruments available to identify uncommon and genetically influenced conditions. This development leads to more individuals receiving diagnoses for conditions treatable by Arcalyst, consequently boosting the demand for the drug. For instance, in February 2024, a report from the Personalized Medicine Coalition (PMC), a US-based non-profit organization, highlighted that the FDA approved 16 new personalized treatments for rare disease patients in 2023, a considerable rise from the six approvals recorded in 2022. Additionally, in February 2023, the PMC stated that the FDA granted approval for 12 new personalized medicines in 2022, marking the eighth consecutive year where personalized medicines made up at least a quarter of all new drug approvals. Consequently, the escalating demand for personalized medicines is fueling the growth of the arcalyst (rilonacept) market.
Which Segment-Based Categories Are Covered In The Arcalyst (rilonacept) Market?
The arcalyst (rilonacept) market covered in this report is segmented –
1) By Type: Lyophilized, Liquid
2) By Indication: Cryopyrin-Associated Periodic Syndromes (CAPS), Deficiency Of Interleukin-1 Receptor Antagonist (DIRA), Other Indications
3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By End User: Adult Patients, Pediatric Patients
Which Trends Are Influencing The Direction Of The Arcalyst (rilonacept) Market?
Leading firms in the Arcalyst (rilonacept) sector are prioritizing expanding its approved uses, specifically including interleukin 1 trap therapy for recurrent pericarditis, aiming for a stronger competitive edge. Interleukin-1 trap therapy works by blocking surplus IL-1 proteins to diminish detrimental inflammation within the body. An example is May 2024, when Kiniksa Pharmaceuticals, a US-based biopharmaceutical company, secured FDA approval for Arcalyst in recurrent pericarditis, characterized by weekly subcutaneous dosing, dual IL 1α/IL 1β blockade, and a positive safety profile for long-term application. This development expands the eligible patient demographic for Arcalyst beyond its initial Cryopyrin-Associated Periodic Syndromes (CAPS) indication. Nonetheless, its wider application might subject the drug to heightened competition, extended safety surveillance, and closer examination from payors.
Which Key Players Are Active In The Arcalyst (rilonacept) Market?
Major companies operating in the arcalyst (rilonacept) market are Regeneron Pharmaceuticals Inc., Kiniksa Pharmaceuticals Ltd.
Access The Complete Arcalyst (rilonacept) Market Report:
https://www.thebusinessresearchcompany.com/report/arcalyst-rilonacept-global-market-report-
Which Region Is The Dominant Market In The Arcalyst (rilonacept) Market?
North America was the largest region in the arcalyst (rilonacept) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arcalyst (rilonacept) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model